Login / Signup

Novel selective PDE type 1 inhibitors cause vasodilatation and lower blood pressure in rats.

Morten LaursenLilliana BeckJan KehlerClaus Tornby ChristoffersenChristoffer BundgaardSusie MogensenTomas Joachim MowEstéfano PinillaJakob Schöllhammer KnudsenElise Røge HedegaardMorten GrunnetUlf Simonsen
Published in: British journal of pharmacology (2017)
These novel PDE1 inhibitors induce vasodilation and lower BP, suggesting a potential use of these vasodilators in the treatment of hypertension and vasospasm.
Keyphrases
  • blood pressure
  • subarachnoid hemorrhage
  • hypertensive patients
  • heart rate
  • combination therapy
  • metabolic syndrome
  • human health
  • climate change
  • cerebral ischemia
  • replacement therapy
  • glycemic control